Cell apoptosis is believed to be one of the main mechanisms of NAFL progression to NASH and NASF, suggesting the possibility of GLP1-RA-based treatment of NAFLD. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.